Skip to main content
Alice Chen, MD, Oncology, Bethesda, MD

Alice P Chen MD

Oncology•Bethesda, MD

Physician

Join to view full profile

  • 10 Center DrBethesda, MD 20892

  • Phone+1 301-496-1196

Dr. Chen is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Chen's full profileAlready have an account?

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1991
  • University of Texas Southwestern Medical Center/St Paul Medical Center
    University of Texas Southwestern Medical Center/St Paul Medical CenterResidency, Internal Medicine, 1987 - 1989
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Internal Medicine, 1986 - 1987
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 1986

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1997 - 2028
  • TX State Medical License
    TX State Medical License 1988 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Effect of Capivasertib in Patients with an AKT1 E17K-Mutated Tumor  
    Kevin Kalinsky, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Alice P Chen, Keith T Flaherty, JAMA Oncology

Authored Content

  • Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
  • Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
  • Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018

Press Mentions

  • Long-Term Use of Immunotherapy May Be Safe for Patients with Alveolar Soft Part Sarcoma
    Long-Term Use of Immunotherapy May Be Safe for Patients with Alveolar Soft Part SarcomaApril 18th, 2026
  • Slips, Slides: Winter Injuries Can Be Serious
    Slips, Slides: Winter Injuries Can Be SeriousJanuary 2nd, 2023
  • Drug Approved to Help Young Patients Battle a Rare Cancer
    Drug Approved to Help Young Patients Battle a Rare CancerJanuary 2nd, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Alice Chen, Dr. Alice Chen, MD, Dr. A Chen, Dr. Alice P Chen